Literature DB >> 32525232

Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial.

Thomas Menter1, Stefanie Hayoz2, Emanuele Zucca3,4,5, Eva Kimby6, Stefan Dirnhofer1, Alexandar Tzankov1.   

Abstract

Entities:  

Keywords:  RORγt; Th17 T cells; follicular lymphoma; gene expression profiling; lenalidomide

Year:  2020        PMID： 32525232     DOI： 10.1111/bjh.16876

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial.

Authors:  Shinya Rai; Hiroaki Inoue; Hitoshi Hanamoto; Mitsuhiro Matsuda; Yasuhiro Maeda; Yusuke Wada; Takahiro Haeno; Yosaku Watatani; Takahiro Kumode; Chikara Hirase; J Luis Espinoza; Yasuyoshi Morita; Hirokazu Tanaka; Yoichi Tatsumi; Itaru Matsumura
Journal:  Int J Hematol       Date:  2021-04-17       Impact factor: 2.490

2.  Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma.

Authors:  Cédric Ménard; Delphine Rossille; Joelle Dulong; Tien-Tuan Nguyen; Ilenia Papa; Maelle Latour; Nadège Bescher; Isabelle Bezier; Myriam Chouteau; Thierry Fest; Roch Houot; Franck Morschhauser; Karin Tarte
Journal:  Blood Adv       Date:  2021-04-27

Review 3.  [Histomorphological patterns of regional lymph nodes in COVID-19 lungs].

Authors:  Jasmin D Haslbauer; Matthias S Matter; Anna K Stalder; Alexandar Tzankov
Journal:  Pathologe       Date:  2021-02-11       Impact factor: 1.011

4.  Histomorphological patterns of regional lymph nodes in COVID-19 lungs.

Authors:  Jasmin D Haslbauer; Matthias S Matter; Anna K Stalder; Alexandar Tzankov
Journal:  Pathologe       Date:  2021-05-05       Impact factor: 1.011

Review 5.  An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date.

Authors:  Umut Yilmaz; Ayse Salihoglu; Teoman Soysal
Journal:  Drug Des Devel Ther       Date:  2021-09-07       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.